SampleID,BarcodeSequence,LinkerPrimerSequence,ReversePrimer,run_prefix,pub_id,Sex,Visit,visitRank,RXCode,Description
Sample-57,TTACGC,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH3VWZ201,096-282,Male,9,1,T1,"NYVAC (2) & placebo mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)"
Sample-58,TTAGGT,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH3VWZ201,096-282,Male,12,2,T1,"NYVAC (2) & placebo mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)"
Sample-60,TTCCAC,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH3VWZ201,096-176,Female,9,1,T1,"NYVAC (2) & placebo mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)"
Sample-61,TTGTAC,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH3VWZ201,096-176,Female,12,2,T1,"NYVAC (2) & placebo mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)"
Sample-62,TTGTGT,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH3VWZ201,096-123,Female,12,1,T4,"DNA & placebo & AIDSVAX B/E mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)"
Sample-63,TATCAC,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH3VWZ201,096-049,Female,9,1,T2,"NYVAC (2) & AIDSVAX B/E mo(0,1,3,6)"
Sample-64,TATGCC,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH3VWZ201,096-049,Female,12,2,T2,"NYVAC (2) & AIDSVAX B/E mo(0,1,3,6)"
Sample-66,TACTAC,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH3VWZ201,096-288,Female,9,1,T1,"NYVAC (2) & placebo mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)"
Sample-67,TACGTT,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH3VWZ201,096-238,Female,9,1,T3,"DNA & placebo (2) mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)"
Sample-68,TCTTAC,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH3VWZ201,096-238,Female,12,2,T3,"DNA & placebo (2) mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)"
Sample-70,TCACTC,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH3VWZ201,096-132,Female,9,1,C3,"placebo (3) mo(0,1) + placebo (2) & AIDSVAX B/E placebo mo(3,6)"
Sample-71,TCGGTT,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH3VWZ201,096-132,Female,12,2,C3,"placebo (3) mo(0,1) + placebo (2) & AIDSVAX B/E placebo mo(3,6)"
Sample-72,TGTTCT,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH3VWZ201,096-151,Female,12,1,T4,"DNA & placebo & AIDSVAX B/E mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)"
Sample-73,TGAAGT,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH3VWZ201,096-162,Male,9,1,T3,"DNA & placebo (2) mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)"
Sample-74,TGACTT,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH3VWZ201,096-162,Male,12,2,T3,"DNA & placebo (2) mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)"
Sample-75,TGACAC,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH3VWZ201,096-089,Male,12,1,T4,"DNA & placebo & AIDSVAX B/E mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)"
Sample-76,TGCATT,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH3VWZ201,096-045,Male,9,1,T3,"DNA & placebo (2) mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)"
Sample-77,TGGAAC,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH3VWZ201,096-045,Male,12,2,T3,"DNA & placebo (2) mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)"
Sample-78,TTACGC,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH5DUPV01,096-281,Female,2,1,T1,"NYVAC (2) & placebo mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)"
Sample-79,TTAGGT,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH5DUPV01,096-281,Female,9,2,T1,"NYVAC (2) & placebo mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)"
Sample-80,TTCTCC,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH5DUPV01,096-281,Female,12,3,T1,"NYVAC (2) & placebo mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)"
Sample-81,TTCCAC,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH5DUPV01,096-208,Female,12,1,T2,"NYVAC (2) & AIDSVAX B/E mo(0,1,3,6)"
Sample-82,TTGTAC,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH5DUPV01,096-236,Male,9,1,T3,"DNA & placebo (2) mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)"
Sample-84,TATCAC,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH5DUPV01,096-019,Male,9,1,T1,"NYVAC (2) & placebo mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)"
Sample-85,TATGCC,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH5DUPV01,096-019,Male,12,2,T1,"NYVAC (2) & placebo mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)"
Sample-86,TAATCC,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH5DUPV01,096-290,Female,12,1,T4,"DNA & placebo & AIDSVAX B/E mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)"
Sample-87,TACTAC,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH5DUPV01,096-003,Female,2,1,T1,"NYVAC (2) & placebo mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)"
Sample-88,TACGTT,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH5DUPV01,096-003,Female,9,2,T1,"NYVAC (2) & placebo mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)"
Sample-89,TCTTAC,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH5DUPV01,096-021,Male,9,1,T2,"NYVAC (2) & AIDSVAX B/E mo(0,1,3,6)"
Sample-90,TCAACC,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH5DUPV01,096-021,Male,12,2,T2,"NYVAC (2) & AIDSVAX B/E mo(0,1,3,6)"
Sample-91,TCACTC,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH5DUPV01,096-247,Female,12,1,T3,"DNA & placebo (2) mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)"
Sample-92,TCGGTT,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH5DUPV01,096-175,Female,12,1,T4,"DNA & placebo & AIDSVAX B/E mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)"
Sample-93,TGTTCT,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH5DUPV01,096-040,Male,2,1,T1,"NYVAC (2) & placebo mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)"
Sample-94,TGAAGT,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH5DUPV01,096-040,Male,12,2,T1,"NYVAC (2) & placebo mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)"
Sample-95,TGACTT,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH5DUPV01,096-063,Female,2,1,C4,"placebo (2) & AIDSVAX B/E placebo mo(0,1,3,6)"
Sample-96,TGACAC,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH5DUPV01,096-063,Female,9,2,C4,"placebo (2) & AIDSVAX B/E placebo mo(0,1,3,6)"
Sample-97,TGCATT,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH5DUPV01,096-063,Female,12,3,C4,"placebo (2) & AIDSVAX B/E placebo mo(0,1,3,6)"
Sample-98,TGGAAC,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH5DUPV01,096-092,Female,9,1,T3,"DNA & placebo (2) mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)"
Sample-D,ATGGAT,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH3VWZ201,NA,,NA,NA,,
db1,AATAGC,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH3VWZ201,NA,,NA,NA,,
buffer,AACTTC,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH3VWZ201,NA,,NA,NA,,
pyro-ntc-1,AACACC,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH3VWZ201,NA,,NA,NA,,
pyro-ntc-2,AACCGT,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH3VWZ201,NA,,NA,NA,,
Sample-E,ATGGAT,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH5DUPV01,NA,,NA,NA,,
Sample-F,AATAGC,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH5DUPV01,NA,,NA,NA,,
db2,AACTTC,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH5DUPV01,NA,,NA,NA,,
db3,AACACC,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH5DUPV01,NA,,NA,NA,,
pyro-ntc-3,AACCGT,GCGGACTACCVGGGTATCTAAT,"GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC",JH5DUPV01,NA,,NA,NA,,
